# IONIS PHARMACEUTICALS INC (IONS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from IONIS PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IONS/mda/fy2025/): filed 2026-02-26; accession 0000874015-26-000115 (https://www.sec.gov/Archives/edgar/data/874015/000087401526000115/form10k.htm); latest 10-K
- [FY 2024 MD&A](/company/IONS/mda/fy2024/): filed 2025-02-19; accession 0000874015-25-000089 (https://www.sec.gov/Archives/edgar/data/874015/000087401525000089/form10k.htm)
- [FY 2023 MD&A](/company/IONS/mda/fy2023/): filed 2024-02-21; accession 0000874015-24-000116 (https://www.sec.gov/Archives/edgar/data/874015/000087401524000116/form10k.htm)
- [FY 2022 MD&A](/company/IONS/mda/fy2022/): filed 2023-02-22; accession 0000874015-23-000105 (https://www.sec.gov/Archives/edgar/data/874015/000087401523000105/form10k.htm)
- [FY 2021 MD&A](/company/IONS/mda/fy2021/): filed 2022-02-25; accession 0000874015-22-000079 (https://www.sec.gov/Archives/edgar/data/874015/000087401522000079/form10k.htm)

Back to /company/IONS/